Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury

PHASE1RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Ischemic Heart DiseaseLung InjuryNon-cardiac Surgery
Interventions
BIOLOGICAL

human umbilical cord-derived mesenchymal stem cells

In the MSCs injection group, 1×10\^6/kg human umbilical cord-derived mesenchymal stem cells were intravenously injected to the patient immediately after the surgery and at day 3 after the surgery.

OTHER

saline

In the control group, saline containing 2% albumin (2ml/kg) were intravenously injected to the patient immediately after the surgery and at day 3 after the surgery.

Trial Locations (1)

200120

RECRUITING

Shanghai East Hospital, Shanghai Tongji University, Shanghai

All Listed Sponsors
lead

Shanghai East Hospital

OTHER